HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Antonio Ruggiero Selected Research

Platinum Compounds (Compounds, Platinum)

10/2022Long-term auditory follow-up in the management of pediatric platinum-induced ototoxicity.
1/2021Cisplatin-induced nephrotoxicity in children: what is the best protective strategy?
1/2016The ability of mannitol to decrease cisplatin-induced nephrotoxicity in children: real or not?
11/2013Platinum compounds in children with cancer: toxicity and clinical management.
10/2013Incidence, clinical features and management of hypersensitivity reactions to chemotherapeutic drugs in children with cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Antonio Ruggiero Research Topics

Disease

38Neoplasms (Cancer)
06/2022 - 10/2002
13Pain (Aches)
11/2021 - 01/2008
12Glioma (Gliomas)
01/2021 - 10/2002
6Brain Neoplasms (Brain Tumor)
06/2022 - 06/2004
5Ependymoma
12/2022 - 06/2004
5Hypersensitivity (Allergy)
11/2021 - 05/2002
4Neuroblastoma
11/2021 - 07/2011
4Infections
11/2021 - 01/2002
4Lymphoma (Lymphomas)
01/2021 - 12/2006
4Ewing Sarcoma (Sarcoma, Ewing)
01/2020 - 12/2008
3Cardiotoxicity
01/2021 - 10/2013
3Chronic Pain
01/2021 - 01/2021
3Sarcoma (Soft Tissue Sarcoma)
01/2021 - 02/2006
3Cancer Pain
10/2019 - 01/2009
3Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
06/2019 - 12/2002
3Nausea
06/2018 - 03/2013
3Primitive Neuroectodermal Tumors (PNET)
05/2014 - 02/2006
3Medulloblastoma
05/2014 - 11/2010
2Ototoxicity
10/2022 - 05/2020
2Hearing Loss (Hearing Impairment)
10/2022 - 05/2020
2Cardiovascular Diseases (Cardiovascular Disease)
05/2022 - 10/2013
2Stomatitis
04/2022 - 01/2021
2Mucositis
04/2022 - 01/2021
2Peripheral Nervous System Diseases (PNS Diseases)
11/2021 - 04/2021
2Diffuse Intrinsic Pontine Glioma
01/2021 - 02/2015
2Rhabdomyosarcoma
01/2020 - 04/2019
2Breakthrough Pain
10/2019 - 03/2013
2Neoplasm Metastasis (Metastasis)
07/2018 - 04/2012
2Nocturnal Enuresis (Bedwetting)
07/2018 - 02/2008
2Vomiting
06/2018 - 11/2013
2Myocardial Infarction
05/2018 - 04/2018
2Thrombosis (Thrombus)
04/2018 - 04/2012
2Retinitis Pigmentosa (Pigmentary Retinopathy)
02/2016 - 01/2016
2Vision Disorders (Hemeralopia)
02/2016 - 07/2011
2Optic Nerve Glioma
02/2016 - 07/2011
2Astrocytoma (Pilocytic Astrocytoma)
06/2004 - 05/2002
1Deafness (Deaf Mutism)
10/2022
1Sensorineural Hearing Loss
10/2022
1Metabolic Syndrome (Dysmetabolic Syndrome X)
05/2022
1Dysbiosis
04/2022
1Mouth Neoplasms (Oral Cancer)
04/2022
1Malnutrition (Nutritional Deficiencies)
01/2022
1Hypotension (Low Blood Pressure)
11/2021
1Photophobia (Light Sensitivity)
11/2021
1Neuralgia (Stump Neuralgia)
11/2021
1Hyperalgesia
11/2021
1Capillary Leak Syndrome
11/2021
1Hematologic Diseases (Blood Diseases)
11/2021

Drug/Important Bio-Agent (IBA)

8Nerve Growth Factor (NGF)IBA
01/2021 - 06/2004
6Carboplatin (JM8)FDA LinkGeneric
10/2022 - 05/2002
6Opioid Analgesics (Opioids)IBA
01/2021 - 01/2009
6Temozolomide (Temodar)FDA LinkGeneric
01/2020 - 11/2010
5Platinum Compounds (Compounds, Platinum)IBA
10/2022 - 10/2013
4Cisplatin (Platino)FDA LinkGeneric
10/2022 - 10/2002
4Pharmaceutical PreparationsIBA
02/2021 - 12/2011
4Buprenorphine (Subutex)FDA LinkGeneric
01/2021 - 01/2009
4Etoposide (VP 16)FDA LinkGeneric
01/2020 - 10/2002
4Antineoplastic Agents (Antineoplastics)IBA
06/2019 - 01/2005
4Methotrexate (Mexate)FDA LinkGeneric
06/2019 - 12/2002
4Ophthalmic Solutions (Eye Drops)IBA
02/2016 - 07/2011
3Biomarkers (Surrogate Marker)IBA
05/2022 - 11/2011
3Fentanyl (Sublimaze)FDA LinkGeneric
01/2021 - 10/2019
2PlatinumIBA
10/2022 - 05/2020
2Proteins (Proteins, Gene)FDA Link
02/2021 - 01/2017
2Nerve Growth Factors (Neurotrophins)IBA
01/2021 - 06/2004
2Phosphotransferases (Kinase)IBA
01/2021 - 01/2021
2dipinacoline glutamateIBA
01/2021 - 02/2015
2Biological ProductsIBA
01/2021 - 03/2020
2KetamineFDA LinkGeneric
01/2021 - 12/2011
2Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2021 - 12/2016
2AnthracyclinesIBA
01/2021 - 10/2013
2Doxorubicin (Adriamycin)FDA LinkGeneric
01/2020 - 10/2013
2Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
01/2018 - 04/2012
2Deamino Arginine Vasopressin (Desmopressin)FDA LinkGeneric
02/2008 - 01/2002
1Hormones (Hormone)IBA
06/2022
1Growth Hormone (Somatotropin)IBA
06/2022
1CytokinesIBA
04/2022
1Complement System Proteins (Complement)IBA
11/2021
1Gabapentin (Neurontin)FDA LinkGeneric
11/2021
1AntigensIBA
11/2021
1Morphine (MS Contin)FDA LinkGeneric
11/2021
1AntibodiesIBA
11/2021
1dinutuximabIBA
11/2021
1Vincristine (Oncovin)FDA LinkGeneric
04/2021
1Histones (Histone)IBA
02/2021
1OTX015IBA
02/2021
1TropomyosinIBA
01/2021

Therapy/Procedure

24Therapeutics
10/2022 - 01/2002
22Drug Therapy (Chemotherapy)
10/2022 - 10/2002
6Radiotherapy
01/2021 - 10/2002
3Topical Administration
02/2016 - 07/2011
2Salvage Therapy
12/2022 - 11/2018
2Catheters
01/2021 - 07/2010
2Investigational Therapies (Experimental Therapy)
12/2020 - 01/2020
2Combined Modality Therapy
07/2018 - 01/2018
2Stents
04/2018 - 03/2017
2Analgesia
01/2009 - 01/2008
1Immunotherapy
11/2021
1Antibiotic Prophylaxis
11/2021
1Splenectomy
11/2021